ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ATXS Astria Therapeutics Inc

9.55
0.20 (2.14%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Astria Therapeutics Inc ATXS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.20 2.14% 9.55 13:00:06
始値 安値 高値 終値 前日終値
9.50 9.36 9.86 9.55 9.35
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0305:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
2024/4/0921:00BWAstria Therapeutics Appoints Sunil Agarwal to Its Board of..
2024/4/0405:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
2024/3/2520:30BWAstria Therapeutics Announces Positive Initial..
2024/3/0606:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
2024/3/0507:22EDGAR2Form 8-K - Current report
2024/3/0507:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0506:10BWAstria Therapeutics Reports Fourth Quarter and Full Year..
2024/3/0506:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2022:00BWAstria Therapeutics to Present at Upcoming American Academy..
2024/2/1505:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1505:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1422:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0622:00BWAstria Therapeutics to Present at Upcoming Oppenheimer 34th..
2024/2/0606:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
2024/1/3123:00EDGAR2Form 8-K - Current report
2024/1/3122:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/3107:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/3023:08BWAstria Therapeutics Announces Pricing of $125 Million..
2024/1/3020:01EDGAR2Form 8-K - Current report
2024/1/3006:39EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1706:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0522:30EDGAR2Form 8-K - Current report
2024/1/0306:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0214:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/2904:09EDGAR2Form S-3/A - Registration statement under Securities Act of..
2023/12/2106:30EDGAR2Form 8-K - Current report
2023/12/1522:30EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/12/0506:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
2023/11/2722:00BWAstria Therapeutics to Present STAR-0215 Data at the 2023..
2023/11/2122:00BWAstria Therapeutics to Present at Upcoming 6th Annual..
2023/11/1406:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1322:06EDGAR2Form 8-K - Current report
2023/11/1322:00BWAstria Therapeutics Reports Third Quarter Financial Results..
2023/11/1022:00BWAstria Therapeutics Presents New Phase 1a Data Confirming..
2023/11/0922:00BWAstria Therapeutics to Present at Upcoming Jefferies London..
2023/11/0321:10BWAstria Therapeutics to Present New STAR-0215 Data at the..
2023/11/0305:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
2023/10/3021:00BWAstria Therapeutics to Report Third Quarter 2023 Financial..
2023/10/1306:04EDGAR2Form 8-K - Current report
2023/10/1306:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/1221:00EDGAR2Form 8-K - Current report
2023/10/1208:14BWAstria Therapeutics Announces Pricing of $64 Million..
2023/10/1206:14EDGAR2Form 8-K - Current report

最近閲覧した銘柄

Delayed Upgrade Clock